Your browser doesn't support javascript.
loading
A safe and effective use of caplacizumab in pregnancy-related acquired thrombotic thrombocytopenic purpura.
Odetola, Oluwatobi; Martin, Karlyn A; Dreyer, Marie; Rajan, Priya; Zakarija, Anaadriana; Stein, Brady L.
Afiliação
  • Odetola O; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Martin KA; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Dreyer M; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Rajan P; Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Zakarija A; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Stein BL; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Br J Haematol ; 202(4): 879-882, 2023 08.
Article em En | MEDLINE | ID: mdl-37226361
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Trombótica Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Trombótica Idioma: En Ano de publicação: 2023 Tipo de documento: Article